title: Essential Medicines in the United States--Why Access Is Diminishing.
authors.affiliation: From the Division of Infectious Diseases (J.D.A., W.M.S.) and the Center for Bioethics and Division of General Internal Medicine (J.S.), University of Minnesota, Minneapolis.
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Alpern
authors.affiliation: From the Division of Infectious Diseases (J.D.A., W.M.S.) and the Center for Bioethics and Division of General Internal Medicine (J.S.), University of Minnesota, Minneapolis.
authors.forename: John
authors.initials: J
authors.lastname: Song
authors.affiliation: From the Division of Infectious Diseases (J.D.A., W.M.S.) and the Center for Bioethics and Division of General Internal Medicine (J.S.), University of Minnesota, Minneapolis.
authors.forename: William M
authors.initials: WM
authors.lastname: Stauffer
mesh_terms: D004339:Drug Compounding; D016527:Drug Costs / Q000639:trends*; D004345:Drug Industry / Q000191:economics* / Q000941:ethics; D018954:Drugs, Essential / Q000191:economics / Q000600:supply & distribution*; D004465:Economic Competition; D033161:Government Regulation; D006801:Humans; D017149:Private Sector; D014481:United States; D014944:World Health Organization
chemical_list: D018954:Drugs, Essential